XWPHARMA LTD.
26Patents
26Active
26Granted
60Portfolio score
Filing activity: Mar 6, 2020 → Jan 24, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11395801B2 | Modified release compositions of a gamma-hydroxybutyric acid derivative | Human Necessities | 6 | Active |
| US11279669B2 | Methods of synthesizing 4-valyloxybutyric acid | Emerging Cross-Sectional Technologies | 1 | Active |
| US11420955B2 | Compounds as neuronal histamine receptor-3 antagonists and uses thereof | Human Necessities | 1 | Active |
| US12172980B2 | Compounds as neuronal histamine receptor-3 antagonists and uses thereof | Human Necessities | 0 | Active |
| US11944597B2 | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11510892B2 | Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US12337066B2 | Controlled release granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
| US11357734B2 | Pharmaceutical granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
| US11896573B2 | Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11440874B2 | Ketamine derivatives and compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US11925710B2 | Modified release compositions of a GAMMA-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
| US11767313B2 | Compounds as nuclear transport modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12234226B2 | Compounds as nuclear transport modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11690811B2 | Pharmaceutical compositions and oral dosage forms of ketamine derivatives | Human Necessities | 0 | Active |
| US11149006B2 | Compounds as neurokinin-1 receptor antagonists and uses thereof | Human Necessities | 0 | Active |
| US11312703B2 | Reactive oxygen species scavengers and use for treating diseases | Human Necessities | 0 | Active |
| US11304906B2 | Controlled release granulations of water-soluble active pharmaceutical ingredients | Human Necessities | 0 | Active |
| US12030834B2 | Methods of synthesizing 4-valyloxybutyric acid | Emerging Cross-Sectional Technologies | 0 | Active |
| US11639337B2 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Human Necessities | 0 | Active |
| US12209060B2 | Ketamine derivatives and compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US11401249B2 | Bicyclic heteroaryl derivatives and preparation and uses thereof | Human Necessities | 0 | Active |
| US12396966B2 | Pharmaceutical compositions and oral dosage forms of ketamine derivatives | Human Necessities | 0 | Active |
| US11692008B2 | Preparation and uses of reactive oxygen species scavenger derivatives | Human Necessities | 0 | Active |
| US11746081B2 | Methods of synthesizing 4-valyloxybutyric acid | Emerging Cross-Sectional Technologies | 0 | Active |
| US12396956B2 | Modified release compositions of a gamma-hydroxybutyric acid derivative | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.